A new oral therapy for prostate cancer, abiraterone acetate (Zytiga), has been launched in the UK and is likely to become available on the NHS in the New Year if a review by the National Institute for Health & Clinical Excellence(NICE) is favourable.
Read Press ReleaseAnaheim, CA 9/16/2011 - Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.
Read Press ReleaseCenters for Specialty Care Group, a network of rehab centers in New York, contributed to the annual Wyckoff Hospital Cancer Survivor Picnic by providing free beauty makeovers and gifts to survivors and other guests.
Read Press ReleaseAccording to attendee Catherine Case Szarwark, the November 4, 2010 Adults in Toyland Casino Night proved to be a highly successful event. Catherine Case Szarwark reported that the event raised both funds and awareness.
Read Press ReleaseJeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects.
Read Press ReleaseMethod of stopping production of cancerous cells including cancerous stem cells, destroying the existing ones and preventing the appearance of new generations of cancerous cells, by using potential telomerase inhibitors in an 'in vitro' setting.
Read Press ReleaseAnticort is a drug intended for the treatment of incurable cancers, where all the other therapeutic means had been exhausted and the patient gave up treatment, but not yet ready for hospice and "end of life" solution.
Read Press ReleaseA major international cancer conference is to be held at the European Parliament during 7-9 September 2011, to examine the importance of using a patient's perception and experience when undergoing new and pioneering clinical trials, which can help,
Read Press ReleaseDr. Jerry Michael Foster MD, a veteran medical practitioner in the greater Nashville, TN area announces a new transition. Using his many years of experience in the fields of internal medicine and oncology.
Read Press ReleaseIsaac Eliaz, M.D., L.Ac., M.S., a world-renowned pioneer in natural medicine, shares the latest news in the prevention and treatment of cancer at the American Academy of Anti-Aging Medicine (A4M) Integrative Oncology Fellowship.
Read Press ReleaseLakewood/Long Beach, CA 6/23/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the upcoming addition of Dr. Cannon Milani to the team of Oncologi
Read Press ReleaseIntervention Insights, Inc., a company that offers a personalized medicine service for oncologists, released a report summarizing the inaugural conference, Personalized Medicine: Promises and Perils for Community Oncology and Payers.
Read Press ReleaseDowney, CA 6/10/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the upcoming addition of Dr. Alexander Gaitanis as part of an expansion of thei
Read Press ReleaseGlendale, CA 5/19/2011 - Dr. Richy Agajanian, founder of The Oncology Institute of Hope and Innovation, recently announced his intention to dedicate more of his time to the Glendale clinic in an effort to better serve the San Gabriel Valley. The l
Read Press ReleaseWhittier, CA 4/12/2011 - Dr. Jack H Freimann was selected "Top Oncologist" by the International Association of Oncologists. Dr. Freimann works for The Oncology Institute of Hope and Innovation, the leader in providing comprehensive cancer trea
Read Press ReleaseRadiation therapy is one of the primary weapons used to fight cancer in modern medicine. It works by delivering precise doses of radiation to cancerous tumours within the body, with the aim of destroying the tumour's cells.
Read Press ReleaseToday marks a major advance in the fight against skin cancer, as the U.S. Food and Drug Administration (FDA) approved a new immune-based therapy for the treatment of melanoma, the leading cause of death from skin cancer.
Read Press ReleaseIMER, an oncology continuing education company, will offer a free live webcast on advanced melanoma. This unique event is part of the 6 symposia series IMER will offer during the ONS 36th Annual Congress in Boston.
Read Press ReleaseDr. Davis will expand upon the findings in Davis's latest book, Disconnect: The Truth about Cell Phone Radiation, What the Industry Has Done to Hide It, and How to Protect Your Family (Dutton, 2010), in which she argues that the most popular gadget
Read Press ReleaseDelhi's first, Third Generation VMAT Radiation Technology is now available for IMRT, IGRT, SRS, SRT and SBRT with Arc Therapy at Dharamshila Hospital And Research Centre for cancer treatment in India.
Read Press ReleaseMesothelioma News is a public service of Baron & Budd that seeks to provide valuable, relevant information about mesothelioma cancer treatments, physicians, veteran asbestos cancer issues and mesothelioma attorneys.
Read Press ReleaseGlendale, CA 2/8/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment has continued to grow its reach within the Southern California community with a new pres
Read Press ReleaseCCC Diagnostics has obtained expanded health care coverage for the DirectHit Panel for Breast Cancer. DirectHit™ provides information about the tumor that may be used its to prescribe the most effective anticancer drug treatment.
Read Press ReleaseLa Mirada, CA 1/14/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the addition of Dr. Rehana Baqai as part of an expansion into La Mirada.
Read Press ReleaseCCC Diagnostics, Inc. has received a grant of $244,479.25 under the Qualifying Therapeutic Discovery Project created by Congress as a component of the Patient Protection and Affordable Care Act of 2010, signed into law by President Obama on March 23
Read Press ReleaseDirectRooms.com reports that the leading physicians in the field of cancer management will be heading to the city of Damascus in January to take part in an important training session
Read Press ReleaseThe study is a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
Read Press ReleaseNITA (Nucletron India Training Academy), which will offer advanced training to radiation oncologists, medical professionals and medical students, was launched at Chennai in a glittering ceremony by Dr Shanta, Cancer Institute, Adyar.
Read Press ReleaseThis annual global health awareness campaign is promoted by major breast cancer organizations every October to increase awareness of the disease as well as to raise funds for research, prevention and finding a cure. RocknBauble goes pink.
Read Press ReleaseInstitute for Myeloma and Bone Cancer Research's Fall Art Benefit offers an afternoon of art appreciation and auction, wine, and hors d'oeuvres at the Andrew Weiss Gallery in Beverly Hills, California.
Read Press ReleaseWater-Jel Technologies, a world leader in advanced emergency burn care products, has announced the launch of its new breakthrough skincare program for radiation burn care called Radiaderm™ Advanced Skincare System with Lactokine™.
Read Press ReleaseRocknBauble donates a percentage of all Leukemia Awareness Jewelry sales to charity and promotes awareness through sharing important Leukemia information and resources through their websites. One major resource for Leukemia Research is the LLS.
Read Press ReleaseA study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has potential in predicting the progr
Read Press ReleaseEngaged in Supplying and manufacturing of Cytotoxic chemotherapy drugs, anti cancer drugs, Supportive Care Therapy drugs, Hematological drugs such as PACLIGET, OXALIGET, TEMOGET, IPOFOS, CARBOGET, CISGET, ETOGET, GLUTAMAC, ZOLEGET, AMIGET, DECMAX etc
Read Press ReleaseDURHAM, NC (August 3, 2010)  The Board of Directors of the Society for Translational Oncology (STO), after an extensive search, is pleased to name Ms Gabriella (Gabby) Cruze, CCMEP, as its inaugural Executive Director.
Read Press ReleaseImmunotherapy made a giant leap forward this weekend with the release of clinical trial results of BMS's ipilimumab. The results indicate that ipilimumab significantly improved the survival of patients with late stage melanoma.
Read Press ReleaseResearchers at Weill Cornell Medical Center in New York have demonstrated that a reovirus therapy called REOLYSIN works synergistically with gemcitabine and may be worth further investigation.
Read Press Release